AZN - Astrazeneca plc - ADR
IEX Last Trade
87.62
0.320 0.365%
Share volume: 2,836,761
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$87.30
0.32
0.37%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-10 | 2023-02-21 | 2023-04-27 | 2023-07-28 | 2023-11-09 | 2024-02-20 | 2024-04-25 | 2024-07-25 | |
| Total revenue | 10.982 B | 11.208 B | 10.879 B | 11.416 B | 11.492 B | 12.024 B | 12.679 B | 12.938 B | |
| Cost of revenue | 2.982 B | 2.900 B | 1.905 B | 1.960 B | 2.095 B | 2.308 B | 2.218 B | 2.183 B | |
| Gross profit | 8.000 B | 8.308 B | 8.974 B | 9.456 B | 9.397 B | 9.716 B | 10.461 B | 10.755 B | |
| 3.85% | 8.02% | 5.37% | -0.62% | 3.39% | 7.67% | 2.81% | |||
| Operating expenses | 6.861 B | 7.402 B | 6.804 B | 7.784 B | 7.513 B | 8.589 B | 7.413 B | 8.069 B | |
| Selling general and admin | 4.403 B | 4.777 B | 4.193 B | 5.117 B | 4.929 B | 5.516 B | 4.630 B | 5.061 B | |
| Research and development | 2.458 B | 2.625 B | 2.611 B | 2.667 B | 2.584 B | 3.073 B | 2.783 B | 3.008 B | |
| Total expenses | 9.843 B | 10.302 B | 8.709 B | 9.744 B | 9.608 B | 10.897 B | 9.631 B | 10.252 B | |
| 4.66% | -15.46% | 11.88% | -1.40% | 13.42% | -11.62% | 6.45% | |||
| Operating income | 1.139 B | 906.000 M | 2.170 B | 1.672 B | 1.884 B | 1.127 B | 3.048 B | 2.686 B | |
| Ebit | 1.246 B | 639.000 M | 2.549 B | 2.455 B | 1.943 B | 1.000 M | 3.102 B | 2.740 B | |
| Pretax income | 922.000 M | 779.000 M | 2.262 B | 2.088 B | 1.652 B | 897.000 M | 2.800 B | 2.397 B | |
| -15.51% | 190.37% | -7.69% | -20.88% | -45.70% | 212.15% | -14.39% | |||
| Income tax | -720.000 M | -124.000 M | 458.000 M | 268.000 M | 274.000 M | -62.000 M | 620.000 M | 469.000 M | |
| Net income basic | 1.642 B | 898.000 M | 1.804 B | 1.818 B | 1.374 B | 959.000 M | 2.179 B | 1.927 B | |
| -45.31% | 100.89% | 0.78% | -24.42% | -30.20% | 127.22% | -11.56% | |||
| Net income | 1.642 B | 898.000 M | 1.804 B | 1.818 B | 1.374 B | 959.000 M | 2.179 B | 1.927 B | |
| -45.31% | 100.89% | 0.78% | -24.42% | -30.20% | 127.22% | -11.56% |